default author photo

Rakefet Sidlik Muskatel

University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy

1901 East Road, Unit 1950

Houston, TX 77030

United States

  • University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy

SCHOLARLY PAPERS

1

DOWNLOADS

35

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Safe Non-Myeloablative Allogeneic HSCT for Autoimmune Diabetes Using Donor Derived Veto Cells

Number of pages: 31 Posted: 19 Apr 2021
Rakefet Sidlik Muskatel, Bar Nathansohn-Levy, Shlomit Reich-Zeliger, Michal Mark, Liat Stoler-Barak, Esther Bachar Lustig, Nir Friedman and Yair Reisner
University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, Weizmann Institute of Science - Department of Immunology, Weizmann Institute of Science - Department of Systems Immunology, Weizmann Institute of Science - Department of Immunology, Weizmann Institute of Science - Department of Immunology, University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, Weizmann Institute of Science - Department of Immunology and University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy
Downloads 35 (1,249,711)

Abstract:

Loading...

Allogeneic bone marrow transplantation, autoimmunity, type 1 diabetes mellitus, reduced intensity transplantation, T cell repertoire, immunomodulation